Skip to main content
Skip to footer
About Us
News & Inisghts
Contact Us
Diagnostic Database
Diagnostics 101
Digital Cognitive Assessments
About Digital Cognitive Assessments
DCA Test Characteristics
CSF & PET
Blood-Based Biomarkers
About Blood-Based Biomarkers
BBM Performance Standards
BBM Clinical Integration
BBM Educational Resources
Diagnostics 101
Digital Cognitive Assessments
About Digital Cognitive Assessments
DCA Test Characteristics
CSF & PET
Blood-Based Biomarkers
About Blood-Based Biomarkers
BBM Performance Standards
BBM Clinical Integration
BBM Educational Resources
About Us
News & Inisghts
Contact Us
Diagnostic Database
Diagnostics 101
Digital Cognitive Assessments
About Digital Cognitive Assessments
DCA Test Characteristics
CSF & PET
Blood-Based Biomarkers
About Blood-Based Biomarkers
BBM Performance Standards
BBM Clinical Integration
BBM Educational Resources
Fujirebio: Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio
In vitro diagnostic (IVD) intended to aid healthcare providers in identifying patients with amyloid pathology associated with Alzheimer’s disease.
Target Biomarker
pTau 217/β-Amyloid 1-42 Ratio
Specimen Type
Plasma
Methodology
Immunoassay
Test Code
17970
Note: Performance data not available at this time.